Medicine by its Russian trade name
Procoralan (Кораксан) and alternatives in France
In France ivabradine is sold as Procoralan. It has the same active ingredient as Кораксан; agree any substitution with your doctor.
Ivabradine lowers heart rate in angina and heart failure; sold as Procoralan in France.
- Packages in the catalog
- 4 packages
- Forms
- Film-coated tablet
- Dispensing in France
- Prescription only
- Supply in France
- No shortages reported by ANSM
Forms and strengths in France
According to the official BDPM catalog. Packages declared as supplied to the French market come first. A manager confirms availability.
Alternatives to Procoralan: medicines with the same active ingredients
Medicines registered in France with the same active ingredients (ivabradine), according to the official BDPM catalog. Strengths, forms and excipients may differ; agree any substitution with your doctor.
- IVABRADINE ACCORDFilm-coated tablet · 5 mg, 7.5 mg
- IVABRADINE ALTERScored tablet · 5 mg
- IVABRADINE ALTERTablet · 7.5 mg
- IVABRADINE ARROWFilm-coated tablet scored · 5 mg
- IVABRADINE ARROWFilm-coated tablet · 7.5 mg
- IVABRADINE BIOGARANFilm-coated tablet scored · 5 mg
- IVABRADINE BIOGARANFilm-coated tablet · 7.5 mg
- IVABRADINE CRISTERSFilm-coated tablet scored · 5 mg
- IVABRADINE CRISTERSFilm-coated tablet · 7.5 mg
- IVABRADINE EGFilm-coated tablet · 5 mg, 7.5 mg
- IVABRADINE KRKAFilm-coated tablet scored · 5 mg
- IVABRADINE KRKAFilm-coated tablet · 7.5 mg
Showing 12 of 18. All medicines with Ivabradine hydrochloride →
Active ingredient
Why Кораксан may be missing from Russian pharmacies
A medicine can disappear from Russian pharmacies when its registration lapses or is suspended, the manufacturer leaves the market, supplies are interrupted or procurement changes. LekInfo does not track stock in Russian pharmacies: we show which forms and strengths are registered in France according to the official BDPM database and help you work it out in a consultation.
Prescription
In France Procoralan is a prescription-only medicine. Prescribing is a doctor’s decision; a manager will tell you which documents the consultation needs.
How to get a consultation about Procoralan
- 1. Find a medicine
Search by name, active ingredient or code. Information comes from BDPM, the official French medicines database.
- 2. Build a list
Add the medicines you have questions about to your consultation list and set the quantities.
- 3. Send a request
Choose how to reach you: email, Telegram, WhatsApp or phone. No account needed.
- 4. Get a manager’s reply
A manager will clarify the medicine details, check that they are current and explain the possible options. We usually reply within 2 hours during working hours.
Questions and answers
Where can I find Кораксан if Russian pharmacies have none?
In France Procoralan is registered and listed in the official BDPM database: the catalog has 4 packages. Send a request to a manager, who will check that the information is current and explain the possible options. The consultation is free; we usually reply within 2 hours during working hours.
How much does Procoralan cost in France?
Reference guide: ≈ €31 per package depending on form and strength. This is BDPM reference data excluding delivery, not an offer to sell; a manager confirms the final terms.
What alternatives to Procoralan exist in France?
BDPM lists medicines with the same active ingredients (ivabradine): Procoralan, Ivabradine Accord, Ivabradine Alter and others. Strengths and forms may differ; agree any substitution with your doctor.
Is a prescription needed for Procoralan?
Yes, in France Procoralan is prescription-only. A manager will tell you which documents are needed.
Is Procoralan the same as Кораксан?
Procoralan is a French medicine with the same active ingredient (ivabradine). Excipients, strengths and forms may differ; agree any substitution with your doctor.
This is reference information, not advertising or an offer to sell, and it does not replace a doctor’s advice. Source: BDPM, the official French medicines database (ANSM), catalog version of 2 November 2026.